KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Minority Interest: 2020-2022

Historic Minority Interest for Ginkgo Bioworks Holdings (DNA) over the last 1 years, with Sep 2022 value amounting to $5.0 million.

  • Ginkgo Bioworks Holdings' Minority Interest fell 92.47% to $5.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $5.0 million, marking a year-over-year decrease of 92.47%. This contributed to the annual value of $62.0 million for FY2021, which is 614.78% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Minority Interest stood at $5.0 million for Q3 2022, which was down 84.19% from $31.6 million recorded in Q2 2022.
  • In the past 5 years, Ginkgo Bioworks Holdings' Minority Interest ranged from a high of $66.4 million in Q3 2021 and a low of $5.0 million during Q3 2022.
  • In the last 3 years, Ginkgo Bioworks Holdings' Minority Interest had a median value of $32.4 million in 2022 and averaged $34.5 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Minority Interest surged by 614.78% in 2021 and then plummeted by 92.47% in 2022.
  • Over the past 3 years, Ginkgo Bioworks Holdings' Minority Interest (Quarterly) stood at $8.7 million in 2020, then soared by 614.78% to $62.0 million in 2021, then plummeted by 92.47% to $5.0 million in 2022.
  • Its Minority Interest was $5.0 million in Q3 2022, compared to $31.6 million in Q2 2022 and $33.3 million in Q1 2022.